Carrie Lachance - 16 May 2025 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 May 2025, 18:55:08 UTC
Prior SEC filing
19 May 2025
Next SEC filing
25 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin Whitman, Attorney-in-Fact for Carrie Lachance

Key filing fact

Carrie Lachance filed Form 4 for InfuSystem Holdings, Inc (INFU) on 20 May 2025.

Key facts

  • This page summarizes Carrie Lachance's Form 4 filing for InfuSystem Holdings, Inc (INFU).
  • 6 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 20 May 2025, 18:55.

Change

  • Previous filing in this sequence was filed on 19 May 2025.
  • Current net transaction value: -$37,454.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001790024 Primary reporting owner

Lachance Carrie

Relationship
President and COO, Director
Address
C/O INFUSYSTEM HOLDINGS, INC., 3851 WEST HAMLIN ROAD, ROCHESTER HILLS
Signature
/s/ Kevin Whitman, Attorney-in-Fact for Carrie Lachance
Signature date
20 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INFU transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+17,727
Change %
+9.3%
Price
$0.000000
Shares after
207,939
Date
17 May 2025
Ownership
Direct
INFU transaction

Common Stock

Tax liability

Transaction value
$37,454
Shares
-6,090
Change %
-2.9%
Price
$6.15
Shares after
201,849
Date
17 May 2025
Ownership
Direct
Footnotes
F1
INFU holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
190,212
Date
16 May 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INFU transaction Derivative

Stock Options (right to buy)

Award

Transaction value
$0
Shares
+74,228
Change %
Price
$0.000000
Shares after
74,228
Date
16 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
74,228
Exercise price
$6.00
Footnotes
F2
INFU transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+128,000
Change %
Price
$0.000000
Shares after
128,000
Date
16 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
128,000
Exercise price
$6.00
Footnotes
F2
INFU transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+31,250
Change %
Price
$0.000000
Shares after
31,250
Date
16 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
31,250
Exercise price
Footnotes
F3, F4
INFU transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-17,727
Change %
-100%
Price
$0.000000
Shares after
0
Date
17 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,727
Exercise price
Footnotes
F3, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of the common stock issued on May 17, 2025

Footnote F2

The option, representing the right to purchase a total of 74,228 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 16, 2026.

Footnote F3

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F4

These restricted stock units vest in three equal annual installments beginning on May 16, 2026.

Footnote F5

These restricted stock units cliff vested on May 17, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .